Document Detail

Local formation of angiotensin II in the rat aorta: effect of endothelium.
MedLine Citation:
PMID:  2198975     Owner:  NLM     Status:  MEDLINE    
1. The local formation of angiotensin II (AII) from its precursors, angiotensin I (AI) and tetradecapeptide (TDP) renin substrate, was studied in intact (with endothelium) and rubbed (without endothelium) aortic rings of the rat. 2. AI and TDP renin substrate maximally contracted intact tissues in a similar way to AII. The same observations were made in rubbed tissues. 3. The maximal response and the sensitivity of the aorta to these agonists were greater in rubbed than in intact tissues. 4. In intact preparations, methylene blue increased the contractile response to AII and TDP to the same extent as endothelium removal. 5. In intact preparations, AII receptor blockade completely suppressed all contractile responses, converting enzyme inhibition completely blocked the responses to AI and TDP, and renin inhibition partially blocked the responses to TDP. 6. In rubbed preparations, AII receptor blockade completely inhibited all contractile responses, converting enzyme inhibition completely suppressed the responses to AI but only partially inhibited those to TDP, and renin inhibition partially blocked the responses to TDP. 7. In conclusion, the formation of AII from TDP and its blockade by a converting enzyme inhibitor and a renin inhibitor shows that converting enzyme and a renin-like aspartic proteinase are present in the aortic wall. Furthermore, the results show that the endothelium is not essential for the conversion of the TDP to AII, but modulates the responses to locally formed AII through the release of endothelium-derived relaxing factor (EDRF).
C Eglème; F Cressier; J M Wood
Related Documents :
2831145 - Converting enzyme activity and angiotensin metabolism in the dog brainstem.
8817875 - Purification and assay methods for angiotensin-converting enzyme.
6250745 - Effect of sulfhydryl reagents on the enzymatic activity of human renin: implications fo...
15947865 - Amp-forming acetyl-coa synthetase from the extremely halophilic archaeon haloarcula mar...
813545 - Allozymic variation as an estimate of heterozygosity in belgian pig breeds.
9139735 - Purification and reconstitution of the vacuolar h+-atpases from lemon fruits and epicot...
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  British journal of pharmacology     Volume:  100     ISSN:  0007-1188     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  1990 Jun 
Date Detail:
Created Date:  1990-09-13     Completed Date:  1990-09-13     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  237-40     Citation Subset:  IM    
Department of Cardiovascular Research, Ciba-Geigy Ltd., Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin I / metabolism
Angiotensin II / biosynthesis*
Angiotensinogen / metabolism,  pharmacology
Aorta, Thoracic / drug effects,  metabolism
Endothelium, Vascular / metabolism*
Methylene Blue / pharmacology
Muscle Contraction / drug effects
Muscle, Smooth, Vascular / drug effects,  metabolism*
Nitric Oxide / pharmacology
Rats, Inbred Strains
Renin / metabolism
Reg. No./Substance:
10102-43-9/Nitric Oxide; 11002-13-4/Angiotensinogen; 11128-99-7/Angiotensin II; 61-73-4/Methylene Blue; 9041-90-1/Angiotensin I; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The rationale for controlling dietary lipids in the prevention of coronary heart disease.
Next Document:  Immunohistological reassessment of accessory cell populations in normal and diseased human synovium.